The Central and Eastern Europe Fund, Inc.

NYSE:CEE

16.26 (USD) • At close September 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q2
Revenue -4.3522.3780.7782.147-1.833-3.614-10.8429.7821.6427.784-7.3368.6181.4336.9042.735.1091.3914.1381.4864.9171.6056.7652.1039.2834.44413.3592.32700
Cost of Revenue 0.3030.3120.2460.2290.1960.1880.6681.0080.8940.8170.9781.0100000000000000000
Gross Profit 02.3780.7781.919-2.029-3.802-11.518.7740.7486.967-8.3147.6081.4336.9042.735.1091.3914.1381.4864.9171.6056.7652.1039.2834.44413.3592.32700
Gross Profit Ratio 0110.8931.1071.0521.0620.8970.4550.8951.1330.88311111111111111100
Reseach & Development Expenses 00000000000000000000000000000
General & Administrative Expenses 00.5740.3710.1240.1930.2050.460.5990.5360.50.5950.6421.1931.2091.3081.3341.1681.0651.1251.2951.4471.9422.3462.5042.7842.6822.88200
Selling & Marketing Expenses 00.0140.0080.0030.0050.0080.0070.0080.0080.0060.0070.0050.0140.0170.0170.0180.0180.0130.020.0230.0230.0250.0270.0350.0240.0480.02600
SG&A 00.5890.3790.1270.1980.2130.4670.6070.5440.5050.6020.6481.2081.2261.3251.3521.1861.0781.1451.3181.471.9672.3742.5392.8072.7292.90800
Other Expenses 0000.127-00-156.7770000000000000000000000
Operating Expenses 00.5890.3790.2546.8514.79985.04916.97424.1116.76825.0845.55415.02713.0332.05916.13319.2866.7039.3241.58313.27421.56474.8995.8017.56119.849-12.77500
Operating Income 20.2821.7890.3991.9413.954-8.128-168.28741.27148.988-7.137-47.62621.1160.2255.6791.4053.7570.2053.0590.3413.60.1354.798-0.276.7441.63710.63-0.58200
Operating Income Ratio -4.6610.7520.5130.904-7.6122.24915.5214.21929.841-0.9176.4932.450.1570.8220.5150.7350.1470.7390.2290.7320.0840.709-0.1280.7260.3680.796-0.2500
Total Other Income Expenses Net 06.0549.758-0.0140.032-0.02384.14917.5810.0373.562-0.06616.75916.234-11.8073.38417.48520.472-5.62410.466-40.265-11.804-19.596-72.5268.3410.368-17.1215.68400
Income Before Tax 20.2837.84320.3133.88113.985-8.151-168.27641.22249.025-7.15-47.692016.46-6.1294.78921.24220.677-2.56510.807-36.666-11.669-14.799-72.79615.08312.005-6.4915.10200
Income Before Tax Ratio -4.6613.29826.0951.807-7.632.25615.524.21429.863-0.9186.502011.486-0.8881.7544.15714.861-0.627.271-7.456-7.269-2.188-34.6091.6252.701-0.4866.49100
Income Tax Expense 00000-084.149-20.66-0.1422.690016.234-11.8073.38417.48520.472-5.62400000000000
Net Income 20.2837.84310.1573.88113.985-8.151-168.27641.22249.025-7.15-47.6926.71116.46-6.1294.78921.24220.677-2.56510.807-36.666-11.669-14.799-72.79615.08312.005-6.4915.10200
Net Income Ratio -4.6613.29813.0481.807-7.632.25615.524.21429.863-0.9186.5020.77911.486-0.8881.7544.15714.861-0.627.271-7.456-7.269-2.188-34.6091.6252.701-0.4866.49100
EPS 3.151.211.610.622.24-1.31-27.056.557.59-1.09-7.1112.42-0.90.682.942.78-0.341.34-4.48-1.34-1.58-6.881.340.98-0.51.1600
EPS Diluted 3.151.211.610.622.24-1.31-27.056.557.59-1.09-7.1112.42-0.90.682.942.78-0.341.34-4.48-1.34-1.58-6.881.340.98-0.51.1600
EBITDA 20.282010.1533.89513.954-8.128-168.28741.27148.988-7.137-47.62621.12516.234-11.8073.38417.48520.472-5.62410.466-40.265-11.804-19.596-72.5268.3410.368-17.1215.68400
EBITDA Ratio -4.661013.0431.814-7.6122.24915.5214.21929.841-0.9176.4932.45111.329-1.711.2393.42214.714-1.3597.041-8.188-7.353-2.897-34.4810.8982.333-1.2826.74100